Investors Purchase High Volume of AFLAC Call Options (NYSE:AFL)

AFLAC Incorporated (NYSE:AFL) saw unusually large options trading activity on Monday. Stock investors acquired 21,689 call options on the stock. This represents an increase of 3,473% compared to the average volume of 607 call options.

AFL stock opened at $52.42 on Wednesday. The company’s 50 day simple moving average is $51.94 and its 200-day simple moving average is $52.28. The firm has a market capitalization of $39.13 billion, a PE ratio of 12.60, a P/E/G ratio of 2.91 and a beta of 0.71. AFLAC has a 12 month low of $41.45 and a 12 month high of $57.18. The company has a debt-to-equity ratio of 0.22, a current ratio of 0.04 and a quick ratio of 0.04.

AFLAC (NYSE:AFL) last released its quarterly earnings results on Thursday, July 25th. The financial services provider reported $1.13 EPS for the quarter, beating the consensus estimate of $1.07 by $0.06. The business had revenue of $5.51 billion for the quarter, compared to analyst estimates of $5.46 billion. AFLAC had a net margin of 14.24% and a return on equity of 12.94%. The company’s quarterly revenue was down 1.4% on a year-over-year basis. During the same period in the prior year, the business earned $1.07 earnings per share. As a group, sell-side analysts anticipate that AFLAC will post 4.36 earnings per share for the current year.

In other news, Director Barbara K. Rimer sold 4,728 shares of the stock in a transaction that occurred on Friday, July 26th. The shares were sold at an average price of $53.74, for a total value of $254,082.72. Following the sale, the director now directly owns 32,448 shares in the company, valued at $1,743,755.52. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, Director Toshihiko Fukuzawa sold 1,500 shares of the stock in a transaction that occurred on Friday, September 27th. The shares were sold at an average price of $52.00, for a total transaction of $78,000.00. Following the completion of the sale, the director now owns 11,349 shares in the company, valued at $590,148. The disclosure for this sale can be found here. Insiders have sold 15,780 shares of company stock worth $835,628 over the last 90 days. 1.30% of the stock is currently owned by company insiders.

Several institutional investors and hedge funds have recently made changes to their positions in AFL. Krane Funds Advisors LLC purchased a new position in shares of AFLAC during the second quarter valued at approximately $25,000. Lenox Wealth Advisors LLC purchased a new position in shares of AFLAC during the third quarter valued at approximately $25,000. Pearl River Capital LLC purchased a new position in shares of AFLAC during the second quarter valued at approximately $27,000. North Star Investment Management Corp. purchased a new position in shares of AFLAC during the third quarter valued at approximately $31,000. Finally, Virtus ETF Advisers LLC purchased a new position in shares of AFLAC during the second quarter valued at approximately $32,000. 64.27% of the stock is currently owned by institutional investors and hedge funds.

Several research firms have recently commented on AFL. Raymond James lowered shares of AFLAC from a “strong-buy” rating to an “outperform” rating and set a $62.00 price target on the stock. in a research report on Monday, July 29th. Evercore ISI lowered shares of AFLAC from an “in-line” rating to an “underperform” rating and set a $56.57 price target on the stock. in a research report on Tuesday, July 16th. Bank of America set a $54.00 price target on shares of AFLAC and gave the company a “hold” rating in a research report on Friday, September 27th. ValuEngine lowered shares of AFLAC from a “sell” rating to a “strong sell” rating in a research report on Thursday, August 1st. Finally, UBS Group increased their price target on shares of AFLAC from $51.00 to $53.00 and gave the company a “neutral” rating in a research report on Thursday, October 10th. Two equities research analysts have rated the stock with a sell rating, six have assigned a hold rating and two have assigned a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus price target of $53.62.

About AFLAC

Aflac Incorporated, through its subsidiaries, provides voluntary supplemental health and life insurance products. It operates through two segments, Aflac Japan and Aflac U.S. The Aflac Japan segment offers voluntary supplemental insurance products, including cancer plans, general medical indemnity plans, medical/sickness riders, care plans, living benefit life plans, ordinary life insurance plans, and annuities in Japan.

Further Reading: The four types of profit margin

Receive News & Ratings for AFLAC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for AFLAC and related companies with MarketBeat.com's FREE daily email newsletter.